Nanotechnology-Based Vaccines for Allergen-Specific Immunotherapy: Potentials and Challenges of Conventional and Novel Adjuvants under Research

Nanotechnology-Based Vaccines for Allergen-Specific Immunotherapy: Potentials and Challenges of Conventional and Novel Adjuvants under Research

The increasing prevalence of allergic diseases demands efficient therapeutic strategies for their mitigation. Allergen-specific immunotherapy (AIT) is the only causal rather than symptomatic treatment method available for allergy. Currently, AIT is being administered using immune response modifiers...

Full description

Bibliographic Details
Main Authors: Litty Johnson, Albert Duschl, Martin Himly
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Vaccines
Subjects:
AIT
allergy
alum
calcium phosphate
microcrystalline tyrosine
CpG oligonucleotide
Online Access:https://www.mdpi.com/2076-393X/8/2/237

Similar Items

Similar Items